α-硫辛酸联合依帕司他治疗糖尿病周围神经病变临床疗效的Meta分析

A meta-analysis of clinical efficacy of a-lipoic acid joint epalrestat treat diabetic peripheral neuropathy

目的客观评价α-硫辛酸联合依帕司他治疗糖尿病周围神经病变(DPN)的疗效。方法通过检索CNKI、VIP、万方数据库,收集近十年来以α-硫辛酸联合依帕司他为治疗组的随机对照试验。对纳入文献进行质量评价,运用Cochrane协作网提供的Rev Man5.3.5软件对数据进行分析,评价α-硫辛酸联合依帕司他治疗糖尿病周围神经病变的疗效。结果共纳入7篇文献,包含570例病例,其中治疗组261例,对照组309例。Meta分析发现,治疗组显效率明显高于对照组,MD=2.26,95%CI[1.56,3.25],差异有统计学意义(P<0.000 1)。此外,治疗组改善感觉正中神经、腓总神经、运动正中神经、腓总神经传导速度优于对照组。结论α-硫辛酸联合依帕司他能够缓解DPN患者症状,改善感觉及运动神经的传导速度,效果明显优于单用α-硫辛酸或依帕司他。

Objective The effect of a-lipoic acid joint epalrestat in treating diabetic peripheral neuropathy was evaluated objectively. Methods By retrieving CNKI,VIP,Wanfang Database,the randomized controlled trial with a-lipoic acid joint Epalrestat treatment was collected over the past decade. The quality of included studies were evaluated and the data was analyzed using the Cochrane Collaboration software provides RevMan5. 3. 5,then assessed the effect of them. Results Seven randomized controlled trial（ 570 cases） were included. Efficiency of improving the symptoms of DPN in combination group was significantly higher（ MD = 2. 26,95% CI [1. 56,3. 25],P〈0. 000 1）. In improving nerve conduction velocity,the effect of combination group was better than the control group. Conclusion The meta-analysis on this group shows that a-lipoic acid joint epalrestat can improve the clinical symptoms in patients with diabetic peripheral neuropathy,and the effects are better than control group in improving nerve conduction velocity.